Accelerating the path to market for microspheres

Unlocking the benefits of microspheres for animal health products

Conventional drug delivery systems present animal health product developers with a range of constraints — from limited bioavailability and uncontrolled active pharmaceutical ingredient (API) release to administration challenges.

Accordingly, industry attention is now turning to a promising novel alternative: controlled-release microspheres.

While microspheres offer numerous advantages relative to more traditional drug delivery technologies, developing a microspheres-based therapy and bringing it to market is challenging.

Embracing these challenges can lead to innovative new products or significant lifecycle opportunities for existing treatments.

Download our insight-packed microspheres eBook and discover:

• What microspheres are
• How they can help you sidestep some of the toughest drug delivery challenges
• The key pitfalls at each stage of the microspheres development and manufacturing process
• How you can overcome them to carve a de-risked, faster, and more cost-effective path to market

Argenta delivers high-quality products and services to our global animal health partners. Our unique 'molecule to market' approach means that we can partner comprehensively across the complete development cycle of a product or step in where we add the most value — from concept to commercialisation.